Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapyPierre Savi, Jean‐Marc Herbert, L. Millet et al.|Journal of Thrombosis and Haemostasis|2008Cited by 64
SR123781A, a Synthetic Heparin MimeticJean‐Marc Herbert, A. Bernat, Pierre Savi et al.|Thrombosis and Haemostasis|2001Cited by 58
Life-Threatening Thrombosis in Mice With Targeted Arg48-to-Cys Mutation of the Heparin-Binding Domain of AntithrombinMieke Dewerchin, Jean‐Marc Herbert, Jean-Pascal Hérault et al.|Circulation Research|2003Cited by 27
Pharmacokinetics of New Synthetic Heparin MimeticsJ P Hérault, Jean‐Marc Herbert, Françoise Bono et al.|Thrombosis and Haemostasis|2002Cited by 20